DermaSensor Inc. raises $16M in Series B funding to expand its FDA-cleared skin cancer detection technology, backed by investors like Pier 70 Ventures and Kern Venture Group.
Amount Raised
$16 Million
Round Type
Series B
MiamiOtherHealthcareHealth CareInvestors
Description
DermaSensor Inc. has raised $16 million in Series B funding to advance its FDA-cleared skin cancer detection solution. The investment includes contributions from existing and new investors, totaling $43 million for the company. With strong market traction, the company aims to enhance early cancer detection in primary care settings
Who to call at DermaSensor, and when
A new round usually means DermaSensor is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day DermaSensor raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at DermaSensor, from your own LinkedIn network
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment DermaSensor raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansDermaSensor raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.